The Impact of Being Clear: Data from the CorEvitas Registry

In this segment, experts discuss key takeaways from the CorEvitas Psoriasis Registry data. They highlight that the level of initial clearance strongly predicts long-term treatment durability. Patients who achieve complete skin clearance (PASI 100) have a significantly lower risk of treatment failure compared to those with even excellent responses like PASI 90 or PASI 75. In fact, the risk of failure was 20 times higher for patients not reaching PASI 75 versus those achieving PASI 100.

This real-world evidence underscores that "super responders" who reach total clearance are more likely to maintain control over time. This data encourages providers to aim for the highest possible treatment targets from the start. It suggests that achieving complete clearance is not just a cosmetic ideal but a critical marker for treatment stability, potentially influenced by factors like earlier intervention and optimal drug selection. Ultimately, striving for PASI 100 is a strategy for long-term success.